Literature DB >> 14053350

THE HORMONE-DEPENDENT CANCERS.

C HUGGINS.   

Abstract

Keywords:  BREAST NEOPLASMS; CYTOLOGY; HORMONES; METABOLISM; NEOPLASM ETIOLOGY; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS

Mesh：

Substances：

Year:  1963        PMID： 14053350     DOI： 10.1001/jama.1963.63710050009008

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  [Experimental studies with cyclic imides in dimethylbenzanthracene tumors of Sprague-Dawley rats].

Authors:  H Mückter; E Frankus; E Moré; W E Kollmer; M Staemmler
Journal:  Z Krebsforsch       Date:  1967

2.  Prognostic significance of gastrin expression in patients undergoing R0 gastrectomy for adenocarcinoma.

Authors:  Michael R Stephens; Andrew N Hopper; Wyn G Lewis; Guy Blackshaw; Paul Edwards; Becky Osborne; Ian W Thompson
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

3.  The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.

Authors:  Julius Semenas; Andreas Hedblom; Regina R Miftakhova; Martuza Sarwar; Rikard Larsson; Liliya Shcherbina; Martin E Johansson; Pirkko Härkönen; Olov Sterner; Jenny L Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

Review 4.  Overcoming drug resistance and treating advanced prostate cancer.

Authors:  Julius Semenas; Cinzia Allegrucci; Stephen A Boorjian; Nigel P Mongan; Jenny Liao Persson
Journal:  Curr Drug Targets       Date:  2012-09-01       Impact factor: 3.465

5.  In vitro effects of oestrogen on 5alpha reduction of testosterone in hormone-dependent rat mammary carcinomata.

Authors:  W R Miller
Journal:  Br J Cancer       Date:  1976-04       Impact factor: 7.640

6.  Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.

Authors:  Ryuhei Kanaoka; Akifumi Kushiyama; Yasuyuki Seno; Yusuke Nakatsu; Yasuka Matsunaga; Toshiaki Fukushima; Yoshihiro Tsuchiya; Hideyuki Sakoda; Midori Fujishiro; Takeshi Yamamotoya; Hideaki Kamata; Akio Matsubara; Tomoichiro Asano
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 7.  Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer.

Authors:  Julius Semenas; Nishtman Dizeyi; Jenny Liao Persson
Journal:  Drug Des Devel Ther       Date:  2013-08-27       Impact factor: 4.162

8.  Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance.

Authors:  Chen Xie; Pen-Jen Lin; Jijun Hao
Journal:  Biomedicines       Date:  2021-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.